Global Cardiopulmonary Bypass Equipment Market

Global Cardiopulmonary Bypass Equipment Market Size Insights Forecasts to 2035

• The Global Cardiopulmonary Bypass Equipment Market Size Was valued at USD 355.29 Million in 2024
• The Global Cardiopulmonary Bypass Equipment Market Size is Expected to Grow at a CAGR of around 4.43% from 2025 to 2035
• The Worldwide Cardiopulmonary Bypass Equipment Market Size is Expected to Reach USD 572.11 Million by 2035
• Asia-Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Decisions Advisors and Consulting, The Global Cardiopulmonary Bypass Equipment Market Size Was Worth Around USD 355.29 Million In 2024 And Is Predicted To Grow To Around USD 572.11 Million By 2035 With A Compound Annual Growth Rate (CAGR) Of 4.43% From 2025 To 2035. Future opportunities in the global cardiopulmonary bypass equipment market will arise from five factors which include rising cardiac surgeries and technological advancements and minimally invasive procedures and emerging markets expansion and increasing adoption of advanced perfusion and monitoring systems.

 

Market Overview

The Global Cardiopulmonary Bypass Equipment Market Size refers to devices used to temporarily take over the function of the heart and lungs during cardiac surgeries. The systems maintain blood circulation and oxygenation which enables surgeons to perform complex surgical operations. The market expands because of three factors which include the increasing number of cardiovascular diseases and the rising demand for open-heart surgeries and the development of new technologies for perfusion systems. Governments across countries are supporting cardiac care through healthcare infrastructure development, public funding for cardiac hospitals, and favorable reimbursement policies. Market growth receives additional support from two factors which include initiatives that promote early heart disease diagnosis and treatment and investments in cutting-edge medical technology. The market experiences growth because of increased healthcare spending and better surgical access in developing countries.

 

Report Coverage

This research report categorizes the cardiopulmonary bypass equipment market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the cardiopulmonary bypass equipment market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the cardiopulmonary bypass equipment market. 

 

Driving Factors

The worldwide market for cardiopulmonary bypass equipment shows growth because of three factors which include rising rates of cardiovascular diseases and the increasing demand for open-heart surgeries and the expanding elderly population and the technological progress of perfusion systems and government programs which enhance cardiac care facilities and provide funding and create access to advanced surgical centers worldwide.

 

Restraining Factors

The market faces multiple obstacles because of expensive equipment costs and high maintenance costs and surgical complications and the need for strict regulatory approvals and the shortage of qualified perfusionists and the rising demand for less invasive cardiac procedures and off-pump surgical methods.

 

Market Segmentation

The cardiopulmonary bypass equipment market share is classified into product and application.

 

• The heart–lung machines segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.           

Based on the product, the cardiopulmonary bypass equipment market is divided into heart–lung machines, oxygenators, autotransfusion systems, and others. Among these, the heart–lung machines segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The widespread use of this procedure in open-heart surgeries together with technological improvements and its dependable results and the growing demand for cardiac surgery at medical facilities and dedicated heart treatment centers worldwide.     

      

• The cardiovascular segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period.     

Based on the application, the cardiopulmonary bypass equipment market is divided into cardiovascular, respiratory, hemodialysis, and others. Among these, the cardiovascular segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The world experiences increasing heart disease rates which lead to more open-heart surgeries and complex cardiac operations and hospitals increasingly adopt cardiopulmonary bypass systems during cardiovascular surgeries and treatment procedures.  

 

Regional Segment Analysis of the Cardiopulmonary Bypass Equipment Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the cardiopulmonary bypass equipment market over the predicted timeframe.

North America is anticipated to hold the largest share of the cardiopulmonary bypass equipment market over the predicted timeframe. The region experiences high cardiovascular disease rates because it has established healthcare systems advanced cardiac surgery centers and it adopted modern cardiopulmonary bypass technologies and its reimbursement systems and major companies operate in the market and the government and private sector both invest heavily in cardiac research and patient care.

 

Asia-Pacific is expected to grow at a rapid CAGR in the cardiopulmonary bypass equipment market during the forecast period. The worldwide demand for cardiac services has increased because of several factors which include rising cardiovascular disease rates and growing elderly populations and better healthcare systems and higher government funding for heart treatment and expanding medical travel and wider usage of modern surgical techniques in developing countries like China and India.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the cardiopulmonary bypass equipment market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Medtronic PLC
• LivaNova PLC
• MAQUET Holding B.V. & Co. KG.
• Terumo Corporation
• Braile Biomedica Ltd
• Tianjin Medical
• Senko Medical Instrument Manufacturing Co. Ltd.
• Abbott
• Becton, Dickinson and Company
• Beijing ZKSK Technology Co., Ltd.
• Nipro Corporation
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Recent Development

 

• In September 2025, Royal Philips launched a new smart telemetry platform for cardiac monitoring, which featured the next-generation Telemetry Monitor 5500. The platform streamlined alarm management, improved workflow, and enhanced continuous patient surveillance, helping hospitals optimize cardiac care and operational efficiency.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the cardiopulmonary bypass equipment market based on the below-mentioned segments: 

 

Global Cardiopulmonary Bypass Equipment Market, By Product

• Heart–Lung Machines
• Oxygenators
• Autotransfusion Systems
• Others

 

Global Cardiopulmonary Bypass Equipment Market, By Application

• Cardiovascular
• Respiratory
• Hemodialysis
• Others

 

Global Cardiopulmonary Bypass Equipment Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  •  South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

 

Frequently Asked Questions (FAQ)

1. What is the CAGR of the cardiopulmonary bypass equipment market over the forecast period?

A: The global cardiopulmonary bypass equipment market is projected to expand at a CAGR of 4.43% during the forecast period.

 

2. What is the market size of the cardiopulmonary bypass equipment market?

A: The global cardiopulmonary bypass equipment market size is estimated to grow from USD 355.29 million in 2024 to USD 572.11 million by 2035, at a CAGR of 4.43% during the forecast period 2025-2035.   

 

3. Which region holds the largest share of the cardiopulmonary bypass equipment market?

A: North America is anticipated to hold the largest share of the cardiopulmonary bypass equipment market over the predicted timeframe.

 

4. Who are the top 10 companies operating in the global cardiopulmonary bypass equipment market?

A: Medtronic PLC, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica Ltd, Tianjin Medical, Senko Medical Instrument Manufacturing Co. Ltd., Abbott, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Nipro Corporation, and Others.

 

5. What are the market trends in the cardiopulmonary bypass equipment market?

A: The main market trends show three main advancements which include better perfusion technologies and increased use of minimally invasive surgical support systems and rising demand for smart monitoring solutions and growing worldwide investment into cardiovascular care infrastructure.